These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 8252800

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G, Brentjens JR, Noble B, Kerjaschki D, Malavasi F, Roholt OA, Farquhar MG, Andres G.
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [Abstract] [Full Text] [Related]

  • 3. Nephritogenicity and immunocytochemical localization of the 70-kilodalton glycoprotein subunit (gp70) of Heymann antigen.
    Singh AK, Schwartz MM.
    Clin Immunol Immunopathol; 1988 Jul; 48(1):61-77. PubMed ID: 3289803
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats.
    Kerjaschki D, Farquhar MG.
    J Exp Med; 1983 Feb 01; 157(2):667-86. PubMed ID: 6337231
    [Abstract] [Full Text] [Related]

  • 6. A major pathogenic antigen of Heymann nephritis is present exclusively in the renal proximal tubule brush border--studies with a monoclonal antibody against pronase-digested tubular antigen.
    Tsukada Y, Ono K, Maezawa A, Yano S, Naruse T.
    Clin Exp Immunol; 1994 May 01; 96(2):303-10. PubMed ID: 8187338
    [Abstract] [Full Text] [Related]

  • 7. Detection of two forms of GP330. Their role in Heymann nephritis.
    Bachinsky DR, Zheng G, Niles JL, McLaughlin M, Abbate M, Andres G, Brown D, McCluskey RT.
    Am J Pathol; 1993 Aug 01; 143(2):598-611. PubMed ID: 8342605
    [Abstract] [Full Text] [Related]

  • 8. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M, Schulze M, Exner M, Kerjaschki D.
    Am J Pathol; 1994 Apr 01; 144(4):807-19. PubMed ID: 8160779
    [Abstract] [Full Text] [Related]

  • 9. Sequential localization of antibody to multiple regions of the glomerular capillary wall in passive Heymann nephritis.
    Rydel JJ, Schwartz MM, Singh AK.
    Lab Invest; 1989 Apr 01; 60(4):492-8. PubMed ID: 2651800
    [Abstract] [Full Text] [Related]

  • 10. Interaction of antibodies with human glomerular epithelial cells.
    Fukatsu A, Yuzawa Y, Olson L, Miller J, Milgrom M, Zamlauski-Tucker MJ, Van Liew JB, Campagnari A, Niesen N, Patel J.
    Lab Invest; 1989 Oct 01; 61(4):389-403. PubMed ID: 2796288
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of cytoplasmic tail-containing form of gp600/megalin in active Heymann nephritis.
    Oleinikov AV, Makker SP.
    J Pathol; 2000 Oct 01; 192(2):251-6. PubMed ID: 11004703
    [Abstract] [Full Text] [Related]

  • 12. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis).
    Kerjaschki D, Neale TJ.
    J Am Soc Nephrol; 1996 Dec 01; 7(12):2518-26. PubMed ID: 8989729
    [Abstract] [Full Text] [Related]

  • 13. Nephritogenicity of antibodies to proteoglycans of the glomerular basement membrane--I.
    Makino H, Gibbons JT, Reddy MK, Kanwar YS.
    J Clin Invest; 1986 Jan 01; 77(1):142-56. PubMed ID: 2935558
    [Abstract] [Full Text] [Related]

  • 14. Identification of a 400-kd protein in the brush borders of human kidney tubules that is similar to gp330, the nephritogenic antigen of rat Heymann nephritis.
    Kerjaschki D, Horvat R, Binder S, Susani M, Dekan G, Ojha PP, Hillemanns P, Ulrich W, Donini U.
    Am J Pathol; 1987 Oct 01; 129(1):183-91. PubMed ID: 2444109
    [Abstract] [Full Text] [Related]

  • 15. Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening.
    Miettinen A, Stow JL, Mentone S, Farquhar MG.
    J Exp Med; 1986 May 01; 163(5):1064-84. PubMed ID: 2939168
    [Abstract] [Full Text] [Related]

  • 16. Preparative polyacrylamide gel electrophoresis in the isolation of the nephritogenic proteins of passive Heymann nephritis.
    Miettinen A, Törnroth T, Vartio T.
    APMIS; 1989 Jun 01; 97(6):479-89. PubMed ID: 2660856
    [Abstract] [Full Text] [Related]

  • 17. [The immune complex pathogenesis of experimental membranous glomerulopathy (Heymann nephritis) and its significance in human glomerular disease].
    Kerjaschki D.
    Verh Dtsch Ges Pathol; 1989 Jun 01; 73():24-35. PubMed ID: 2482609
    [Abstract] [Full Text] [Related]

  • 18. Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.
    Kerjaschki D, Exner M, Ullrich R, Susani M, Curtiss LK, Witztum JL, Farquhar MG, Orlando RA.
    J Clin Invest; 1997 Nov 01; 100(9):2303-9. PubMed ID: 9410908
    [Abstract] [Full Text] [Related]

  • 19. Studies with monoclonal antibodies against brush border antigens in Heymann nephritis.
    Bhan AK, Schneeberger EE, Baird LG, Collins AB, Kamata K, Bradford D, Erikson ME, McCluskey RT.
    Lab Invest; 1985 Oct 01; 53(4):421-32. PubMed ID: 3900581
    [Abstract] [Full Text] [Related]

  • 20. Induction of Heymann nephritis with a gp330/megalin fusion protein.
    Raychowdhury R, Zheng G, Brown D, McCluskey RT.
    Am J Pathol; 1996 May 01; 148(5):1613-23. PubMed ID: 8623929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.